We recently published a list of Jim Cramer Sees Opportunity in Pessimism and Highlights These 12 Stocks. In this article, we ...

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Real life is different. Fathers get down, sometimes debilitatingly. And as new research from Rutgers Health reveals, when ...

Depression is becoming more common among adults and adolescents in the United States, but most are not getting therapy to help, according to a new report from the US Centers for Disease Control and ...

Johnson & Johnson stock slipped Tuesday, even after the company reported first-quarter earnings that surpassed expectations ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

The healthcare-products company on Tuesday said its higher outlook reflects its completed acquisition of mental-illness drug developer Intra-Cellular Therapies. The roughly $15 billion deal in part ...

Meechie Johnson Jr. transferred to Ohio State for the 2024-25 season and was ticketed for a significant role in the rotation. After 10 games, Johnson stepped away from the Buckeyes for what was ...

Taking probiotics may reduce negative mood, according to a new clinical trial. The results build on evidence showing the ...